Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers

Digestive Diseases and Sciences

Volumn 47, Issue 6, 2002, Pages 1399-1404

  Akamatsu, Taiji ^a   Nakamura, Naoshi ^a   Furuya, Naoyuki ^a   Shimizu, Toshiki ^a   Gotou, Akira ^a   Kiyosawa, Kendo ^a   Katsuyama, Tsutomu ^a   Osumi, Takahiko ^b   Hirao, Yukihiro ^b   Miyamoto, Gohatiro ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Drug delivery; Helicobacter pylori; Local concentration; Mucus; Rebamipide

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIULCER AGENT; REBAMIPIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MUCUS; NORMAL HUMAN; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA; STOMACH ULCER; TABLET;

ADMINISTRATION, ORAL; ADULT; ALANINE; ANTI-ULCER AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GASTRIC MUCOSA; HUMANS; MALE; MUCUS; QUINOLONES;

EID: 0036270509     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015347219999     Document Type: Article

References (24)

1. Effect of OPC-12759, a novel antiulcer agent on chronic and acute experimental gastric ulcer and gastric secretion in rats
2. Clinical evaluation of proamipide (OPC-12759) in gastric ulcer: A multicenter double-blind comparison study with cetraxate
3. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa
4. Gastric mucosal protection by OPC-12759, a novel antiulcer compound in rats
5. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats
6. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines
7. Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance
8. Getting to the route of Helicobacter pylori treatment
9. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa
10. Local gastric and serum amoxicillin concentrations after different oral application forms
11. Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice
12. High-performance liquid chromatographic procedure for the determination of a new anti-gastric ulcer agent, 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid, in human plasma and urine
13. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis
14. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants
15. Rebamipide protects against activation of neutrophils by Helicobacter pylori
16. Rebamipide, a gastroprotective drug, improves quality of healing and decreases recurrence of gastric ulcer without affecting Helicobacter pylori status
17. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state
18. Campylobacter pyloridis and gastritis: Association with intracellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium
19. Histochemical study of Helicobacter pylori and surface mucous gel layer in various gastric lesions
20. Helicobacter pylori and the surface mucous gel layer of the human stomach
21. Immunohistochemical detection of Helicobacter pylori in the surface mucous gel layer and its clinicopathological significance
22. Effect of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients
23. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer
24. Modification of Helicobacter pylori adhesion to human gastric epithelial cells by antiadhesion agent